5.24
Abcellera Biologics Inc Aktie (ABCL) Neueste Nachrichten
AbCellera Biologics shareholders approve director elections and auditor at annual meeting - Investing.com
Is AbCellera (ABCL) Using Boardroom Oncology Talent to Redefine Its Clinical Ambitions? - simplywall.st
AbCellera Biologics (ABCL) grants director 111,701 share options - Stock Titan
AbCellera (ABCL) director Stephen Quake awarded 111,701 share options - Stock Titan
AbCellera (ABCL) director receives 111,701 share options grant - Stock Titan
AbCellera (NASDAQ: ABCL) shareholders back directors, auditor and Say-on-Pay - Stock Titan
Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year? - MSN
AbCellera (ABCL) director Sandor Victor reports initial insider status on Form 3 - Stock Titan
Wall Street Analysts Think ABCELLERA BIOLG (ABCL) Could Surge 85.59%: Read This Before Placing a Bet - MSN
AbCellera: Q3 Hot Flashes Data Drop Aside, This Stock Is A Difficult Sell (NASDAQ:ABCL) - Seeking Alpha
Q3 2025 Abcellera Biologics Inc Earnings Call Transcript - GuruFocus
AbCellera Biologics Hits Day Low of $5.50 Amid Price Pressure - Markets Mojo
AbCellera Appoints Dr. Victor Sandor to its Board of Directors - BioSpace
A Look At AbCellera Biologics (ABCL) Valuation After ABCL635 Progress And Strong Q1 Results - Yahoo Finance
AbCellera’s Shift To Proprietary Drugs Puts ABCL635 And Governance In Focus - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
AbCellera appoints Victor Sandor to board of directors - Investing.com UK
AbCellera appoints Victor Sandor to board of directors By Investing.com - Investing.com South Africa
AbCellera Biologics bets on hot flash antibody as pipeline pivot gains steam - MSN
AbCellera Biologics Adds Victor Sandor to Board - TipRanks
AbCellera appoints Victor Sandor to its Board - TradingView
AbCellera (NASDAQ: ABCL) appoints oncology leader Dr. Victor Sandor as independent director - Stock Titan
ABCL News | ABCELLERA BIOLOGICS INC (NASDAQ:ABCL) - ChartMill
Abcellera Biologics Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Q1 2026 Abcellera Biologics Inc Earnings Call Transcript - GuruFocus
Abcellera Biologics Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
AbCellera Biologics Bets on Hot Flash Antibody as Pipeline Pivot Gains Steam - TradingView
ABCL Stock Jumps As Earnings Beat And Drug Data Fuel Momentum - StocksToTrade
ABCL: Lead antibody for menopausal hot flashes advances to phase II, targeting a $6B market - TradingView
AbCellera (NASDAQ: ABCL) CFO exercises 250,000 share options - Stock Titan
Is AbCellera (ABCL) Turning Upgraded Earnings Forecasts Into a Durable Clinical-Stage Business Model? - simplywall.st
AbCellera Biologics Hits Day High with 12.47% Surge in Stock Price - Markets Mojo
AbCellera Biologics Hits Day High with 7.68% Surge in Stock Price - Markets Mojo
AbCellera Biologics Hits New 52-Week High of $6.79, Up 84% - Markets Mojo
Abcellera Biologics stock hits 52-week high at 6.52 USD By Investing.com - Investing.com India
After golden cross, AbCellera Biologics Inc. (ABCL)'s technical outlook is bright - MSN
Has ABCELLERA BIOLG (ABCL) Outpaced Other Medical Stocks This Year? - MSN
Abcellera Biologics stock hits 52-week high at 6.52 USD - Investing.com
AbCellera Biologics (NASDAQ:ABCL) Is In A Good Position To Deliver On Growth Plans - Moomoo
After Golden Cross, AbCellera Biologics Inc. (ABCL)'s Technical Outlook is Bright - Yahoo Finance
ABCL - Finviz
ABCL Technical Analysis & Stock Price Forecast - Intellectia AI
Does AbCellera (ABCL) Have a Clear Path From ABCL635 Data to a Durable Business Model? - Yahoo Finance
AbCellera Biologics Inc. (ABCL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Truist raises AbCellera stock price target on clinical data promise By Investing.com - Investing.com Nigeria
Here’s Why AbCellera (ABCL) is Among the 10 Best Penny Stocks to Buy for Long Term - Insider Monkey
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):